9776 — Sapporo Clinical Laboratory Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMicro CapSuper Stock

Annual cashflow statement for Sapporo Clinical Laboratory, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	1,176	1,502	960	598	700
Depreciation
Non-Cash Items	12	46.4	211	-70.8	10.6
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-622	-522	-259	14.8	-538
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	838	1,574	1,430	1,078	731
Capital Expenditures	-3,153	-948	-826	-448	-1,277
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	4.58	117	417	52.2	36.4
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-3,148	-831	-409	-395	-1,240
Financing Cash Flow Items	-0.001	220	-0.001	-32	-0.001
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	1,944	-113	-348	-370	-526
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-367	630	673	312	-1,035